About BD
BD is a company based in Franklin Lakes (United States) founded in 1897. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 74,000 employees as of September 30, 2024. BD has completed 36 acquisitions, including ATTO Technology, Accuri Cytometers and Alverix. BD offers products and services including BD Vacutainer UltraTouch and BD ChloraPrep.
- Headquarter Franklin Lakes, United States
- Employees 74000 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Becton, Dickinson And Company
-
Annual Revenue
$20.18 B (USD)4.16as on Sep 30, 2024
-
Net Profit
$1.71 B (USD)14.89as on Sep 30, 2024
-
EBITDA
$5.23 B (USD)20.06as on Sep 30, 2024
-
Latest Funding Round
$336.86 K (USD), Grant
Jan 01, 2021
-
Investors
HHS
& 3 more
-
Employee Count
74000
as on Sep 30, 2024
-
Investments & Acquisitions
ATTO Technology
& 35 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BD
BD is a publicly listed company on the NYSE with ticker symbol BDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BD
BD offers a comprehensive portfolio of products and services, including BD Vacutainer UltraTouch and BD ChloraPrep.
Blood collection device ensuring reduced pain during procedure.
Antiseptic solution used for skin preparation before procedures.
People of BD
Unlock access to complete
Unlock access to complete
Software Development Team
289 people
Leadership Team
174 people
Sales and Marketing
153 people
Product Management Team
47 people
Senior Team
43 people
Operations Team
22 people
Human Resources and Administration
16 people
Sr. Team
15 people
Unlock access to complete
Funding Insights of BD
Investors in BD
BD has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and U.S. Department of Defense.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Military forces are provided by the U.S. Department of Defense for national security.
|
Locked | Locked | Locked |
Investor details for BD
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BD
BD has strategically engaged in corporate development activities, having acquired 36 companies. Notable acquisitions include ATTO Technology, Accuri Cytometers and Alverix.
Investment portfolio details for BD
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
App for home-based kit enabled urine diagnosis
|
Locked | Locked | 2018 | Locked | |
|
Point-of-care diagnostics for infectious diseases are developed.
|
Locked | Locked | 2015 | Locked | |
|
Radiofrequency ablation system for treating venous reflux disease
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for BD
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BD
Detailed financials for BD
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bd Comparisons
Peer comparison for BD
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BD
Detailed competitors of BD
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bd
Complete news archive for BD
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BD
BD was founded in 1897 and raised its 1st funding round 111 years after it was founded.
BD is headquartered in Franklin Lakes, United States. It is registered at Franklin Lakes, New Jersey, United States.
Tom Polen is the current CEO of BD.
As of Sep 30, 2024, the latest employee count at BD is 74,000.
Annual revenue of BD is $20.18B as on Sep 30, 2024.
BD, known as Becton Dickinson, is engaged in the development of medical technologies and solutions. The company operates in the healthcare sector, focusing on improving medical discovery, diagnostics, and care delivery. Innovative products and services are offered to enhance safety and efficiency across various healthcare settings. Solutions are designed to support patient care throughout critical life moments, addressing needs in diagnostics and treatment. Operations span globally, with a strong presence in India and other regions.
BD offers BD Vacutainer UltraTouch and BD ChloraPrep.
Yes, BD is publicly traded on NYSE under the ticker symbol BDX.
BD has made 36 acquisitions, including ATTO Technology, Accuri Cytometers, and Alverix.
BD has 4 investors. Key investors include HHS, European Union, U.S. Department of Defense, and Military Health.
The ticker symbol of BD is BDX on NYSE.